Medable, Inc

Medable, Inc is a healthcare technology startup focused on revolutionizing clinical trials. With the slogan "The leading global platform for decentralized clinical trials," Medable's mission is to expedite the delivery of effective therapies to patients. By offering an end-to-end, global cloud platform equipped with a versatile set of tools, the company enables collaboration between sponsors, patients, providers, and CRO's in clinical trials, ultimately aiming to enhance the efficiency of clinical research, healthcare delivery, and precision medicine. Founded in 2016, Medable is headquartered in the United States. The company recently secured a significant $304.00M Series D investment on 26 October 2021. The investment was led by prominent firms including GSR Ventures, Launchpad Digital Health, Sapphire Ventures, Western Technology Investment, and Blackstone Accelerates Growth. This funding reflects the confidence and support of well-established investors in Medable's vision and potential impact in the healthcare and pharmaceutical industries. Medable's vision is to accelerate human discovery and medical cures while driving innovation and empowering consumers. The company's proactive, collaborative, and committed approach underscores its dedication to improving global health. With its focus on leveraging technology to advance clinical trials and healthcare, Medable is poised to contribute significantly to a healthier world.